Peptidyl O-acyl hydroxamates: potent new inactivators of cathepsin B. 1988

R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
Syntex Research, Mississauga, Ontario, Canada.

Peptidyl O-acyl hydroxamates having appropriate active-site recognition features are very potent time-dependent inhibitors of the cysteine proteinase cathepsin B. The inhibition is irreversible, and the inactivation rate is strongly dependent on peptide structure and correct positioning of the P1 amino acid carbonyl group. Lipophilic O-acyl groups provide the most rapid inactivators, as exemplified by the inhibitor O-mesitoyl N-benzyloxycarbonyl-L-phenylalanyl-L-alanine hydroxamate (kmax/Ki = 640,000 M-1s-1).

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002401 Cathepsin B A lysosomal cysteine proteinase with a specificity similar to that of PAPAIN. The enzyme is present in a variety of tissues and is important in many physiological and pathological processes. In pathology, cathepsin B has been found to be involved in DEMYELINATION; EMPHYSEMA; RHEUMATOID ARTHRITIS, and NEOPLASM INVASIVENESS. Cathepsin B-Like Proteinase,Cathepsin B1,Cathepsin B Like Proteinase,Proteinase, Cathepsin B-Like
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
October 1993, Biochimica et biophysica acta,
R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
July 1996, Biochimica et biophysica acta,
R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
November 1989, The Biochemical journal,
R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
June 2020, Journal of medicinal chemistry,
R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
February 1981, The Journal of biological chemistry,
R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
June 1989, Biochimica et biophysica acta,
R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
August 2000, Bioorganic & medicinal chemistry letters,
R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
October 2008, Bioorganic & medicinal chemistry,
R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
December 1991, FEBS letters,
R A Smith, and P J Coles, and R W Spencer, and L J Copp, and C S Jones, and A Krantz
May 1993, FEBS letters,
Copied contents to your clipboard!